(Q62541823)

1

0 references

Pierina Sueli Bonato

3

0 references

C M de Gaitani

1

0 references

V L Lanchote

2

0 references

P S Bonato

Journal of Chromatography B: Biomedical Sciences and Applications

3

0 references

language of work or name

English

0 references

publication date

April 1998

0 references

24 April 1998

0 references

published in

0 references

volume

708

0 references

issue

1-2

0 references

page(s)

177-183

0 references

177-83

0 references

cites work

Clinical pharmacology of propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Congenital complete heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Stereoselective disposition and pharmacologic activity of propafenone enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Metabolite cumulation during chronic propafenone dosing in arrhythmia.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Stereoselective interactions of (R)- and (S)-propafenone with the cardiac sodium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Liquid chromatographic analysis of propafenone enantiomers in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Direct separation of the enantiomers of propafenone, diprafenone and their major metabolites by high-performance liquid chromatography on modified cellulose and amylose chiral stationary phases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Direct enantiomeric high performance liquid chromatographic separation of propafenone and its major metabolite in serum on a cellulose tris-3,5-dimethylphenyl carbamate chiral stationary phase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

A Rapid Procedure for the Purification of Biological Samples to be Analyzed by High Performance Liquid Chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021

Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2897%2900652-X

7 January 2021